Patient population
| Characteristics | Frequency (%) |
| Age | 56.9 (range 43–77) |
| Gender | |
| Female | 17 (42.5) |
| Male | 23 (57.5) |
| Ethnicity | |
| South Asian (Indo-Trinidadian) | 28 (70) |
| Caribbean Black (Afro-Trinidadian) | 7 (17.5) |
| Mixed/Others | 5 (12.5) |
| Body mass index | 26.47 (range 18.48–45.7) |
| Comorbidities | |
| Diabetes mellitus | 22 (55) |
| Hypertension | 28 (70) |
| Dyslipidaemia | 25 (62.5) |
| Chronic kidney disease | 1 (2.5) |
| Cerebrovascular events | 2 (5.0) |
| Chronic obstructive pulmonary disease | 1 (2.5) |
| Peripheral artery disease | 0 (0) |
| Cardiovascular medications | |
| Aspirin | 40 (100) |
| Clopidogrel | 40 (100) |
| ACE inhibitor/angiotensin receptor blocker | 35 (87.5) |
| Beta blocker | 35 (87.5) |
| Statin | 36 (90) |
| Calcium channel blocker | 12 (30) |
| Nitrates | 24 (60) |
| Trimetazidine | 27 (67.5) |
| Mineralocorticoid receptor antagonist | 0 (0) |
| Ivabradine | 0 (0) |
| Insulin | 12 (30) |
| Ejection fraction | |
| 25–34 | 3 (7.5) |
| 35–45 | 8 (20) |
| >46 | 29 (72.5) |
| Platelet reactivity units | |
| >208 | 20 (50) |
| <208 | 20 (50) |
| SYNTAX Score | |
| 0–22 | 32 (80) |
| 23–32 | 5 (12.5) |
| >33 | 3 (7.5) |